About
Zhang Cheng is a Professor of Medicine at the Department of Cardiology, Cheeloo College of Medicine, Shandong University, China. He also serves as Vice Director of the State Key Laboratory for Innovation and Transformation of Luobing Theory and The Key Laboratory of Cardiovascular Remodeling and Function Research (Chinese Ministry of Education and National Health Commission), Qilu Hospital, Shandong University, Jinan, China.
- Ph.D. in Medicine, Baylor College of Medicine, Houston, USA (2004-2009)
- Postdoctoral Researcher, University of Oklahoma Health Sciences Center, USA (2010-2011)
His research focuses on Atherosclerosis, Abdominal Aortic Aneurysm, and Heart Failure, with particular emphasis on molecular mechanisms involving gene regulation, signal transduction pathways, and metabolic interactions in vascular diseases. Recent work explores the role of RNA-binding proteins, AMPK-FOXO3 pathways, and angiogenesis in cardiovascular pathologies.
Key trends in his publications include genetic modulation of vascular smooth muscle function, inflammatory pathways in cardiovascular disease, and novel therapeutic targets such as the β2AR/cAMP/SIRT1 axis and DKK proteins. His studies integrate animal models, clinical biomarkers, and translational approaches.
- 2023 Chinese Award for Medical Science and Technology
- 2023 Shandong Province Science and Technology Progress Award
- 2019 National Ten Thousand Talents Plan - Leading Talents in Science and Technology
- 2018 State Council Natural Science Award
- 2016 Yangtze River Scholar
- 2016 Fellow, American College of Cardiology
- 2015 National Funds for Distinguished Young Scientists
- 2014 Fellow, European Society of Cardiology
His laboratory leads multidisciplinary research into cardiovascular remodeling, diabetic complications, and vascular inflammation, collaborating with international institutions including the University of Oklahoma and EMBL. Current projects investigate novel gene therapies and metabolic-cardiovascular interactions.
